410 related articles for article (PubMed ID: 25712760)
1. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial.
Flichy-Fernández AJ; Ata-Ali J; Alegre-Domingo T; Candel-Martí E; Ata-Ali F; Palacio JR; Peñarrocha-Diago M
J Periodontal Res; 2015 Dec; 50(6):775-85. PubMed ID: 25712760
[TBL] [Abstract][Full Text] [Related]
2. Clinical and microbiological evaluation of the effect of Lactobacillus reuteri in the treatment of mucositis and peri-implantitis: A triple-blind randomized clinical trial.
Galofré M; Palao D; Vicario M; Nart J; Violant D
J Periodontal Res; 2018 Jun; 53(3):378-390. PubMed ID: 29352461
[TBL] [Abstract][Full Text] [Related]
3. Probiotic supplements and debridement of peri-implant mucositis: a randomized controlled trial.
Hallström H; Lindgren S; Widén C; Renvert S; Twetman S
Acta Odontol Scand; 2016; 74(1):60-6. PubMed ID: 25953193
[TBL] [Abstract][Full Text] [Related]
4. The effects of Lactobacillus reuteri probiotics combined with azithromycin on peri-implantitis: A randomized placebo-controlled study.
Tada H; Masaki C; Tsuka S; Mukaibo T; Kondo Y; Hosokawa R
J Prosthodont Res; 2018 Jan; 62(1):89-96. PubMed ID: 28756115
[TBL] [Abstract][Full Text] [Related]
5. Reuterinos
Lauritano D; Carinci F; Palmieri A; Cura F; Caruso S; Candotto V
Int J Immunopathol Pharmacol; 2019; 33():2058738419827745. PubMed ID: 30791748
[TBL] [Abstract][Full Text] [Related]
6. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial.
Iniesta M; Herrera D; Montero E; Zurbriggen M; Matos AR; Marín MJ; Sánchez-Beltrán MC; Llama-Palacio A; Sanz M
J Clin Periodontol; 2012 Aug; 39(8):736-44. PubMed ID: 22694350
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of probiotics in the treatment of peri-implant mucositis: a triple-blind randomized clinical trial.
Peña M; Barallat L; Vilarrasa J; Vicario M; Violant D; Nart J
Clin Oral Investig; 2019 Apr; 23(4):1673-1683. PubMed ID: 30151705
[TBL] [Abstract][Full Text] [Related]
8. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study.
Teughels W; Durukan A; Ozcelik O; Pauwels M; Quirynen M; Haytac MC
J Clin Periodontol; 2013 Nov; 40(11):1025-35. PubMed ID: 24164569
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis.
Szkaradkiewicz AK; Stopa J; Karpiński TM
Arch Immunol Ther Exp (Warsz); 2014 Dec; 62(6):495-500. PubMed ID: 24509697
[TBL] [Abstract][Full Text] [Related]
10. The usage of a lactobacilli probiotic in the non-surgical therapy of peri-implantitis: A randomized pilot study.
Laleman I; Pauwels M; Quirynen M; Teughels W
Clin Oral Implants Res; 2020 Jan; 31(1):84-92. PubMed ID: 31705683
[TBL] [Abstract][Full Text] [Related]
11. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: a preliminary randomized clinical trial.
Vicario M; Santos A; Violant D; Nart J; Giner L
Acta Odontol Scand; 2013; 71(3-4):813-9. PubMed ID: 23176716
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Topical Effect of Probiotic Mouthwash in the Treatment of Patients with Peri-Implant Mucositis.
Sargolzaei N; Arab H; Gerayeli M; Ivani F
J Long Term Eff Med Implants; 2022; 32(1):85-91. PubMed ID: 35377998
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant use of multispecies probiotic in the treatment of peri-implant mucositis: A randomized controlled trial.
Santana SI; Silva PHF; Salvador SL; Casarin RCV; Furlaneto FAC; Messora MR
J Clin Periodontol; 2022 Aug; 49(8):828-839. PubMed ID: 35634695
[TBL] [Abstract][Full Text] [Related]
14. Presence of Lactobacillus reuteri in saliva coincide with higher salivary IgA in young adults after intake of probiotic lozenges.
Braathen G; Ingildsen V; Twetman S; Ericson D; Jørgensen MR
Benef Microbes; 2017 Feb; 8(1):17-22. PubMed ID: 27873545
[TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of the effect of probiotic lactobacillus reuteri on peri-implantitis microflora.
Mulla M; Mulla M; Hegde S; Koshy AV
BMC Oral Health; 2021 Aug; 21(1):408. PubMed ID: 34412595
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Biochemical Evaluation of Lozenges Containing Lactobacillus reuteri as an Adjunct to Non-Surgical Periodontal Therapy in Chronic Periodontitis.
İnce G; Gürsoy H; İpçi ŞD; Cakar G; Emekli-Alturfan E; Yılmaz S
J Periodontol; 2015 Jun; 86(6):746-54. PubMed ID: 25741580
[TBL] [Abstract][Full Text] [Related]
17. Probiotics and mucositis.
Cereda E; Caraccia M; Caccialanza R
Curr Opin Clin Nutr Metab Care; 2018 Sep; 21(5):399-404. PubMed ID: 29916923
[TBL] [Abstract][Full Text] [Related]
18. Clinical effectiveness of
Arbildo-Vega HI; Panda S; Bal A; Mohanty R; Rendón-Alvarado A; Das AC; Cruzado-Oliva FH; Infantes-Ruíz ED; Manfredi B; Vásquez-Rodrigo H; Mortellaro C; Giacomello MS; Parrini M; Greco Lucchina A; Del Fabbro M
J Biol Regul Homeost Agents; 2021; 35(2 Suppl. 1):79-88. PubMed ID: 34281304
[TBL] [Abstract][Full Text] [Related]
19. Effect of tablets containing probiotic candidate strains on gingival inflammation and composition of the salivary microbiome: a randomised controlled trial.
Keller MK; Brandsborg E; Holmstrøm K; Twetman S
Benef Microbes; 2018 Apr; 9(3):487-494. PubMed ID: 29264967
[TBL] [Abstract][Full Text] [Related]
20. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
